Solid Biosciences Incis A Precision Genetic Medicine Company Based In Cambridgemafounded In 2013The Company Is Dedicated To Developing Gene Therapies And Genetic Regulators For Rare Neuromuscular And Cardiac Diseaseswith A Strong Focus On Improving Patient Outcomessolid Biosciences Prioritizes Duchenne Muscular Dystrophydmdand Has Expanded Its Research To Include Friedreichae S Ataxiacatecholaminergic Polymorphic Ventricular Tachycardiaand Genetic Cardiomyopathies The Companyae S Key Productsgt 001Is A Microdystrophin Gene Therapy Aimed At Delivering A Functional Dystrophin Gene To Muscle Cells For Dmd Treatmentsolid Biosciences Also Works On Gene Therapies For Friedreichae S Ataxia And Cpvtalongside Developing Innovative Delivery Platforms And Genetic Regulators To Enhance Therapy Efficacythe Company Engages With Patient Communities And Collaborates With Academic Institutions And Biotech Partners To Advance Its Research And Clinical Programs
